NCT07656857

Brief Summary

What's the clinical value of high-density flexible microelectrocorticography (μECoG) for guiding the resection of epileptogenic zone (EZ) in epilepsy surgery?

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for not_applicable

Timeline
29mo left

Started Jul 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Jul 2026Dec 2028

First Submitted

Initial submission to the registry

June 15, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 18, 2026

Completed
13 days until next milestone

Study Start

First participant enrolled

July 1, 2026

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2028

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

July 8, 2026

Status Verified

June 1, 2026

Enrollment Period

2.1 years

First QC Date

June 15, 2026

Last Update Submit

July 6, 2026

Conditions

Keywords

Epilepsy surgerymicroelectrocorticography (μECoG)

Outcome Measures

Primary Outcomes (1)

  • Seizure Freedom Rate at 6 Months After Surgery

    The proportion of participants who remain free from any type of epileptic seizure during the 6-month postoperative follow-up period.

    From surgery to 6 months postoperatively

Secondary Outcomes (11)

  • Seizure Freedom Rate at 1 Year After Surgery

    From surgery to 1 year postoperatively

  • Postoperative Seizure Outcome According to ILAE Classification

    6 months and 1 year postoperatively

  • Monthly Seizure Frequency

    Baseline, 6 months postoperatively, and 1 year postoperatively

  • Seizure Severity Assessed by the National Hospital Seizure Severity Scale

    Baseline, 6 months postoperatively, and 1 year postoperatively

  • Developmental Function Assessed by the Griffiths Mental Development Scales

    Baseline, 6 months postoperatively, and 1 year postoperatively

  • +6 more secondary outcomes

Study Arms (1)

Intraoperative application of high-density flexible μECoG-Guided Resection

EXPERIMENTAL
Device: Using High-density Flexible microElectrocorticography for intraoperative monitoring

Interventions

During resective epilepsy surgery, a sterile high-density flexible microelectrocorticography will be placed on the exposed cortical surface over the suspected epileptogenic zone and adjacent cortex. The array will be used for high-spatial-resolution intraoperative μECoG recording and real-time analysis of epileptiform activity, including interictal spikes, high-frequency oscillations, spatial discharge gradients, and propagation patterns. The intraoperative ECoG findings will be provided to the surgical team to assist in defining the epileptogenic zone and tailoring the extent of resection. The high-density μECoG is used for intraoperative recording only and will be removed before wound closure.

Intraoperative application of high-density flexible μECoG-Guided Resection

Eligibility Criteria

Age3 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age 3 to 60 years.
  • Diagnosis of drug-resistant epilepsy, defined as persistent seizures despite treatment with two or more appropriately selected, adequately dosed and adequately tried antiseizure medications.
  • Diagnosis of focal epilepsy after standard presurgical evaluation and considered suitable for resective epilepsy surgery.
  • Preoperative cognitive or developmental status sufficient to participate in study assessments, as judged by the investigator and assessed using age-appropriate validated instruments. For participants aged 3 to 6 years, developmental status must be within the normal range according to the Griffiths Mental Development Scales. For participants aged 6 to 16 years, cognitive function must be within the normal range according to the Wechsler Intelligence Scale for Children. For participants older than 16 years, a Mini-Mental State Examination score of 24 or higher will be required.
  • Written informed consent provided by the participant or, when applicable, by a legal guardian.

You may not qualify if:

  • Suspected mesial temporal lobe epilepsy after multidisciplinary presurgical evaluation.
  • History of any previous neurosurgical craniotomy before epilepsy surgery.
  • Severe psychiatric, cognitive, or psychological disorder that prevents participation in the study or completion of follow-up.
  • Contraindication to surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Tiantan Hospital

Beijing, Beijing Municipality, 100070, China

RECRUITING

Related Publications (2)

  • Xingjian Liu, Chao Zhang, Baotian Zhao, et al., Preliminary application study of flexible high-density cortical electrodes in assisting localization of epileptogenic zones during epileptogenic zonectomy, Chinese Journal of Neurosurgery, 2025, 41(12):1237-1244. DOI:10.3760/cma.j.cn112050-20250919-00362

    BACKGROUND
  • Guo J, Wang Z, van 't Klooster MA, Van Der Salm SM, Leijten FS, Braun KP, Zijlmans M. Seizure Outcome After Intraoperative Electrocorticography-Tailored Epilepsy Surgery: A Systematic Review and Meta-Analysis. Neurology. 2024 Jun 11;102(11):e209430. doi: 10.1212/WNL.0000000000209430. Epub 2024 May 20.

    PMID: 38768406BACKGROUND

MeSH Terms

Conditions

Epilepsies, Partial

Interventions

Monitoring, Intraoperative

Condition Hierarchy (Ancestors)

EpilepsyBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Monitoring, PhysiologicDiagnostic Techniques and ProceduresDiagnosisSurgical Procedures, Operative

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Outcome assessors will be blinded to group allocation when evaluating postoperative seizure outcomes. Due to the surgical nature of the intervention, participants, care providers, and investigators cannot be masked.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of the Department of Neurosurgery, Clinical Professor

Study Record Dates

First Submitted

June 15, 2026

First Posted

June 18, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

July 31, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

July 8, 2026

Record last verified: 2026-06

Locations